Skip to main content

Table 5 Factors associated with HPV vaccination acceptance among mothers of 14–18 year old daughters (N=194), univariate and multivariate analysis

From: French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 – 18 year old daughters: a quantitative-qualitative study

N (%)

Favourable (N=114)

Undecided opposed (N=80)

p value

Crude OR

95% CI

Adjusted OR

95% CI

p value

Age1

 ≥ 40 years old

88 (77.2)

69 (86.3)

0.114

1

    

 < 40 years old

26 (22.8)

11 (13.8)

 

1.85

0.56-4.01

   

Employment

 Unemployed/Housewife/Retired

24 (18.2)

21 (32.4)

0.640

1

    

 In employment

90 (81.8)

59 (77.6)

 

1.33

0.68-2.60

   

Social/financial assistance

5 (4.59)

1 (1.4)

0.234

3.62

0.41-31.59

   

Family situation

 Married/Living with a partner

95 (85.6)

68 (85.0)

0.982

1

    

 Single/Divorced/Widowed

19 (14.4)

12 (15.0)

 

1.13

0.51-2.48

   

Vaccination status themselves

 Diphtheria-Tetanus-Poliomyelitis and BCG

111 (97.4)

75 (96.1)

0.630

2.47

0.57-10.65

   

 Measles, Mumps and Rubella

41 (37.3)

36 (48.0)

0.339

0.69

0.39-1.24

   

 Hepatitis B

41 (37.3)

31 (41.3)

0.386

0.89

0.49-1.61

   

Vaccination status of their children

 Diphtheria-tetanus-poliomyelitis and BCG vaccine

113 (99.1)

78 (97.5)

0.367

2.90

0.26-32.54

   

 Measles, Mumps and Rubella

97 (85.1)

65 (81.3)

0.478

1.32

0.62-2.83

   

 Chickenpox

13 (11.4)

7 (8.8)

0.798

1.34

0.51-3.52

   

 Pneumococcus1

27 (23.7)

7 (8.85)

0.007

3.24

1.33-7.86

3.28

1.32-8.11

0.010

 Hepatitis B

57 (52.3)

39 (51.4)

0.991

1.05

0.59-1.86

   

Current smoker1

22 (20.8)

7 (9.09)

0.033

2.62

1.06-6.49

   

Educational level1

 Tertiary

15 (14.3)

17 (24.6)

0.143

1

    

 Upper secondary/non tertiary

35 (33.3)

16 (23.2)

0.051

2.48

0.996-3.99

   

 Primary/lower secondary

55 (52.4)

36 (52.2)

0.185

1.73

0.77-3.90

   

History of STD1

7 (6.1)

9 (11.2)

0.203

0.52

0.18-1.45

   

Yearly gynaecological follow up

76 (68.5)

57 (73.1)

0.602

0.81

0.44-1.51

   

Most recent Pap test within the past three years

101 (90.2)

67 (84.8)

0.262

1.51

0.66-3.46

   

“Pap test aims to prevent CC”

76 (66.7)

54 (67.5)

0.903

0.96

0.52-1.76

   

“Pap test should be performed during the whole of adult life” 1

91 (79.8)

73 (91.3)

0.030

0.38

0.15-0.93

0.32

0.12-0.82

0.018

Have heard of HPV vaccine

112 (98.2)

69 (87.3)

0.004

8.12

1.13-38.1

   

“HPV vaccine is recommended for young adolescent girls before sexual debut” or answer close to this” 1

60 (52.6)

30 (37.5)

0.038

1.85

1.03-3.32

2.12

1.15-3.90

0c016

  1. 1included in multivariate model, OR, odds ratio, CI, confidence interval, CC, cervical cancer, cpo, sexually transmitted disease.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us